Drug recall · April 13, 2022
Travoprost Ophthalmic Solution recall
Why: Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Travoprost Ophthalmic Solution, USP, 0.004%, 2.5 mL bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDC 0378-9651-32.
- Lots / codes
Lot # TV11W101, Exp Mar 2023
- Quantity
- 20,112 bottles
- Company
- Mylan Pharmaceuticals Inc, Morgantown, WV
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- April 1, 2022 · Voluntary: Firm initiated
- Classified
- April 6, 2022
- Reported
- April 13, 2022
- Ended
- February 27, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Travoprost
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.